KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Non-cash Items: 2012-2020

Historic Non-cash Items for Novavax (NVAX) over the last 1 years, with Sep 2020 value amounting to $446.5 million.

  • Novavax's Non-cash Items rose 46664.45% to $446.5 million in Q3 2020 from the same period last year, while for Sep 2020 it was $446.5 million, marking a year-over-year increase of 46664.45%. This contributed to the annual value of $1.0 million for FY2019, which is N/A change from last year.
  • Novavax's Non-cash Items amounted to $446.5 million in Q3 2020, which was up 24.90% from $357.5 million recorded in Q2 2020.
  • In the past 5 years, Novavax's Non-cash Items registered a high of $446.5 million during Q3 2020, and its lowest value of $945,971 during Q2 2019.
  • Its 2-year average for Non-cash Items is $161.4 million, with a median of $1.1 million in 2020.
  • Data for Novavax's Non-cash Items shows a peak YoY spiked of 46,664.45% (in 2020) over the last 5 years.
  • Quarterly analysis of 2 years shows Novavax's Non-cash Items stood at $954,785 in 2019, then spiked by 46,664.45% to $446.5 million in 2020.
  • Its last three reported values are $446.5 million in Q3 2020, $357.5 million for Q2 2020, and $1.1 million during Q1 2020.